Metal-organic frameworks as a therapeutic strategy for lung diseases.
J Mater Chem B
; 10(30): 5666-5695, 2022 08 04.
Article
in English
| MEDLINE | ID: covidwho-1947652
ABSTRACT
Lung diseases remain a global burden today. Lower respiratory tract infections alone cause more than 3 million deaths worldwide each year and are on the rise every year. In particular, with coronavirus disease raging worldwide since 2019, we urgently require a treatment for lung disease. Metal organic frameworks (MOFs) have a broad application prospect in the biomedical field due to their remarkable properties. The unique properties of MOFs allow them to be applied as delivery materials for different drugs; diversified structural design endows MOFs with diverse functions; and they can be designed as various MOF-drug synergistic systems. This review concentrates on the synthesis design and applications of MOF based drugs against lung diseases, and discusses the possibility of preparing MOF-based inhalable formulations. Finally, we discuss the chances and challenges of using MOFs for targeting lung diseases in clinical practice.
Full text:
Available
Collection:
International databases
Database:
MEDLINE
Main subject:
Metal-Organic Frameworks
/
Lung Diseases
Type of study:
Prognostic study
Limits:
Humans
Language:
English
Journal:
J Mater Chem B
Year:
2022
Document Type:
Article
Affiliation country:
D2tb00690a
Similar
MEDLINE
...
LILACS
LIS